These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 18085662

  • 1. The orally-active and selective c-Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen-induced arthritis mouse model.
    Ohno H, Uemura Y, Murooka H, Takanashi H, Tokieda T, Ohzeki Y, Kubo K, Serizawa I.
    Eur J Immunol; 2008 Jan; 38(1):283-91. PubMed ID: 18085662
    [Abstract] [Full Text] [Related]

  • 2. A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model.
    Ohno H, Kubo K, Murooka H, Kobayashi Y, Nishitoba T, Shibuya M, Yoneda T, Isoe T.
    Mol Cancer Ther; 2006 Nov; 5(11):2634-43. PubMed ID: 17121910
    [Abstract] [Full Text] [Related]

  • 3. The selective M-CSF receptor tyrosine kinase inhibitor Ki20227 suppresses experimental autoimmune encephalomyelitis.
    Uemura Y, Ohno H, Ohzeki Y, Takanashi H, Murooka H, Kubo K, Serizawa I.
    J Neuroimmunol; 2008 Mar; 195(1-2):73-80. PubMed ID: 18378004
    [Abstract] [Full Text] [Related]

  • 4. META060 inhibits osteoclastogenesis and matrix metalloproteinases in vitro and reduces bone and cartilage degradation in a mouse model of rheumatoid arthritis.
    Konda VR, Desai A, Darland G, Bland JS, Tripp ML.
    Arthritis Rheum; 2010 Jun; 62(6):1683-92. PubMed ID: 20201075
    [Abstract] [Full Text] [Related]

  • 5. Treatment with N-tosyl-l-phenylalanine chloromethyl ketone after the onset of collagen-induced arthritis reduces joint erosion and NF-kappaB activation.
    Choi J, Ha KH, Byun MS, Min SY, Park MJ, Park HS, Oh HJ, Ju JH, Kim HY, Jue DM.
    Eur J Pharmacol; 2008 Oct 24; 595(1-3):108-13. PubMed ID: 18706406
    [Abstract] [Full Text] [Related]

  • 6. Suppressive effects of Chelidonium majus methanol extract in knee joint, regional lymph nodes, and spleen on collagen-induced arthritis in mice.
    Lee YC, Kim SH, Roh SS, Choi HY, Seo YB.
    J Ethnopharmacol; 2007 May 30; 112(1):40-8. PubMed ID: 17353105
    [Abstract] [Full Text] [Related]

  • 7. Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis.
    Kelchtermans H, Geboes L, Mitera T, Huskens D, Leclercq G, Matthys P.
    Ann Rheum Dis; 2009 May 30; 68(5):744-50. PubMed ID: 18480308
    [Abstract] [Full Text] [Related]

  • 8. Modulation of established murine collagen-induced arthritis by a single inoculation of short-term lipopolysaccharide-stimulated dendritic cells.
    Salazar L, Aravena O, Abello P, Escobar A, Contreras-Levicoy J, Rojas-Colonelli N, Catalán D, Aguirre A, Zúñiga R, Pesce B, González C, Cepeda R, Cuchacovich M, Molina MC, Salazar-Onfray F, Delgado M, Toes RE, Aguillón JC.
    Ann Rheum Dis; 2008 Sep 30; 67(9):1235-41. PubMed ID: 18056756
    [Abstract] [Full Text] [Related]

  • 9. THR0921, a novel peroxisome proliferator-activated receptor gamma agonist, reduces the severity of collagen-induced arthritis.
    Tomita T, Kakiuchi Y, Tsao PS.
    Arthritis Res Ther; 2006 Sep 30; 8(1):R7. PubMed ID: 16356194
    [Abstract] [Full Text] [Related]

  • 10. A selective p38 alpha mitogen-activated protein kinase inhibitor reverses cartilage and bone destruction in mice with collagen-induced arthritis.
    Medicherla S, Ma JY, Mangadu R, Jiang Y, Zhao JJ, Almirez R, Kerr I, Stebbins EG, O'Young G, Kapoun AM, Luedtke G, Chakravarty S, Dugar S, Genant HK, Protter AA.
    J Pharmacol Exp Ther; 2006 Jul 30; 318(1):132-41. PubMed ID: 16597712
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Selective functional inhibition of JAK-3 is sufficient for efficacy in collagen-induced arthritis in mice.
    Lin TH, Hegen M, Quadros E, Nickerson-Nutter CL, Appell KC, Cole AG, Shao Y, Tam S, Ohlmeyer M, Wang B, Goodwin DG, Kimble EF, Quintero J, Gao M, Symanowicz P, Wrocklage C, Lussier J, Schelling SH, Hewet AG, Xuan D, Krykbaev R, Togias J, Xu X, Harrison R, Mansour T, Collins M, Clark JD, Webb ML, Seidl KJ.
    Arthritis Rheum; 2010 Aug 30; 62(8):2283-93. PubMed ID: 20506481
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The non-thiol angiotensin-converting enzyme inhibitor quinapril suppresses inflammatory arthritis.
    Dalbeth N, Edwards J, Fairchild S, Callan M, Hall FC.
    Rheumatology (Oxford); 2005 Jan 30; 44(1):24-31. PubMed ID: 15353612
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 reduces the severity of collagen-induced arthritis.
    Tanaka K, Horikawa T, Suzuki S, Kitaura K, Watanabe J, Gotoh A, Shiobara N, Itoh T, Yamane S, Suzuki R, Fukui N, Ochi T.
    J Rheumatol; 2008 Dec 30; 35(12):2316-24. PubMed ID: 19004048
    [Abstract] [Full Text] [Related]

  • 20. An LFA-1 (alphaLbeta2) small-molecule antagonist reduces inflammation and joint destruction in murine models of arthritis.
    Suchard SJ, Stetsko DK, Davis PM, Skala S, Potin D, Launay M, Dhar TG, Barrish JC, Susulic V, Shuster DJ, McIntyre KW, McKinnon M, Salter-Cid L.
    J Immunol; 2010 Apr 01; 184(7):3917-26. PubMed ID: 20190141
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.